Clinical Trial Update: Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic Agents [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating how gut microbiota responds to hypoglycemic agents in type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Type2 Diabetes Mellitus | Phase 4 | Status: UNKNOWN